
Hemab
Developer of prophylactic therapeutics designed for bleeding and thrombosis disorders. The company's therapeutics accumulate, modulate, balance, and at times recruit endogenous clotting factors alread...
Valuation
$0
Share Price
N/A
Total Raised
$353M
Last Round
N/A